Tenofovir Alafenamide Fumarate Microspheres, Process Parameters for Enhanced Permeability and Liver Targeting
K. Sudhamani & B. Jeevana Jyothi · Journal of Pharmaceutical Research International · 2021
Aims: Chronic hepatitis B (CHB) infection is a serious global health problem and one of the main causes of chronic liver disease, cirrhosis. Tenofovir Alafenamide Fumarate (TAF) is a prodrug of Tenofovir, a nucleotide analogue with limited oral bioavailability. TAF is considered...
Open access
Research Article
10.9734/jpri/2021/v33i41A32317